Abstract
Osteosarcopenia is an increasingly recognized geriatric syndrome with a considerable prevalence which increases morbidity and mortality. Although osteosarcopenia is a result of age-related deterioration in muscle and bone, there are many risk factors that provoking osteosarcopenia. These risk factors should be considered by the clinicians to treat osteosarcopenia. We assessed the link between osteosarcopenia and conventional risk factors of cardiovascular diseases. This study was a cross-sectional study that has been conducted within the framework of Bushehr Elderly Health (BEH) program stage II in which participants aged ≥ 60 years were included. Osteopenia/osteoporosis was defined as a t-score ≤ − 1.0 standard deviation below the mean values of a young healthy adult. We defined sarcopenia as reduced skeletal muscle mass plus low muscle strength and/or low physical performance. Osteosarcopenia was considered as the presence of both osteopenia/osteoporosis and sarcopenia. We estimated the age-standardized prevalence of osteosarcopenia for men and women, separately. Using modified Poisson regression analysis, adjusted prevalence ratio (PR) with 95% CI was used to show the measure of associations in the final model. Among 2353 participants, 1205 (51.2%) were women. Age-standardized prevalence of osteosarcopenia was 33.8 (95% CI 31.0–36.5) in men and 33.9 (30.9–36.8) in women. In both sexes, the inverse association was detected with body mass index and having osteosarcopenia (PR 0.84, 95% CI 0.81–0.88 in men and 0.77, 95% CI 0.74–0.80 in women). In both sexes, high-fat mass was positively associated with osteosarcopenia [PR 1.46 (95% CI 1.11–1.92) in men, and 2.25 (95% CI 1.71–2.95) in women]. Physical activity had a significant inverse association in men (PR = 0.64, 95% CI 0.46, 0.88), but not in women. Diabetes was also showed a direct association with osteosarcopenia in men (PR 1.33, 95% CI 1.04–1.69). No associations were detected between the lipid profiles and osteosarcopenia. Results demonstrated a high prevalence of osteosarcopenia in both sexes suggesting a high disease burden in a rapidly aging country. Lifestyle and socioeconomic factors, as well as chronic diseases, were significantly associated with osteosarcopenia.
Similar content being viewed by others
References
Narici MV, Maffulli N (2010) Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 95:139–159
Consensus development conference: prophylaxis and treatment of osteoporosis (1991). Am J Med 90(1):107–110
World Health Organization (2019) Interesting facts about ageing. https://www.who.int/ageing/about/facts/en. Accessed 25 Jan 2019
Hassan EB, Duque G (2017) Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician 46(11):849–853
Reginster JY, Beaudart C, Buckinx F, Bruyere O (2016) Osteoporosis and sarcopenia: two diseases or one? Curr Opin Clin Nutr Metab Care 19(1):31–36
Yoo JI, Ha YC (2018) Review of epidemiology, diagnosis, and treatment of osteosarcopenia in Korea. J Bone Metab 25(1):1–7
Varenna M, Manara M, Galli L, Binelli L, Zucchi F, Sinigaglia L (2013) The association between osteoporosis and hypertension: the role of a low dairy intake. Calcif Tissue Int 93(1):86–92
Dominguez LJ, Muratore M, Quarta E, Zagone G, Barbagallo M (2004) Osteoporosis and diabetes. Reumatismo 56(4):235–241
Migliaccio S, Greco EA, Fornari R, Donini LM, Lenzi A (2011) Is obesity in women protective against osteoporosis? Diabetes Metab Syndr Obes 4:273–282
Aubertin-Leheudre M, Lord C, Goulet ED, Khalil A, Dionne IJ (2006) Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring) 14(12):2277–2283
Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, Okumura S et al (2010) A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol 110(1):57–65
Davison KK, Ford ES, Cogswell ME, Dietz WH (2002) Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc 50(11):1802–1809
Goulet ED, Lord C, Chaput JP, Aubertin-Leheudre M, Brochu M, Dionne IJ (2007) No difference in insulin sensitivity between healthy postmenopausal women with or without sarcopenia: a pilot study. Appl Physiol Nutr Metab 32(3):426–433
Oterdoom LH, Gansevoort RT, Schouten JP, de Jong PE, Gans RO, Bakker SJ (2009) Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis 207(2):534–540
Metter EJ, Talbot LA, Schrager M, Conwit R (2002) Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A 57(10):B359–B365
Chin SO, Rhee SY, Chon S, Hwang YC, Jeong IK, Oh S et al (2013) Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PLoS ONE 8(3):e60119
Shafiee G, Ostovar A, Heshmat R, Darabi H, Sharifi F, Raeisi A et al (2017) Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ Open 7(8):e013606
Ostovar A, Nabipour I, Larijani B, Heshmat R, Darabi H, Vahdat K et al (2015) Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system). BMJ Open 5(12):e009597
Aadahl M, Andreasen AH, Hammer-Helmich L, Buhelt L, Jorgensen T, Glumer C (2013) Recent temporal trends in sleep duration, domain-specific sedentary behaviour and physical activity. A survey among 25–79-year-old Danish adults. Scand J Public Health 41(7):706–711
Aadahl M, Jorgensen T (2003) Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc 35(7):1196–1202
World Health Organization. WHO Criteria for Diagnosis of Osteoporosis. https://www.4bonehealth.org/education/world-health-organization-criteria-diagnosis-osteoporosis/. Accessed 25 Jan 2019
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101
Shafiee G, Ostovar A, Heshmat R, Keshtkar AA, Sharifi F, Shadman Z et al (2018) Appendicular skeletal muscle mass reference values and the peak muscle mass to identify sarcopenia among Iranian healthy population. Int J Prev Med 9:25
American Heart Association, National Heart, Lung, and Blood Institute, Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 13(6):322–327
Hill KD, Farrier K, Russell M, Burton E (2017) Dysmobility syndrome: current perspectives. Clin Interv Aging 12:145–152
Carol S (2017) Intake: energy. In: Krause’s food and the nutrition care process, 14th edn. Elsevier, Inc., New York
Kaji H (2014) Interaction between muscle and bone. J Bone Metab 21(1):29–40
Kang SY, Lim GE, Kim YK, Kim HW, Lee K, Park TJ et al (2017) Association between sarcopenic obesity and metabolic syndrome in postmenopausal women: a cross-sectional study based on the Korean National Health and Nutritional Examination Surveys from 2008 to 2011. J Bone Metab 24(1):9–14
Yoo JI, Kim H, Ha YC, Kwon HB, Koo KH (2018) Osteosarcopenia in patients with hip fracture is related with high mortality. J Korean Med Sci 33(4):e27
Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R, FiAT Intervention Group (2016) Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 28(5):895–899
Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW et al (2015) Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc 16(4):290–295
Wang YJ, Wang Y, Zhan JK, Tang ZY, He JY, Tan P et al (2015) Sarco-osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol 2015:482940
Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R (2002) Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 75(4):683–688
Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28(10):2781–2790
Demontiero O, Boersma D, Suriyaarachchi P, Duque G (2014) Clinical outcomes of impaired muscle and bone interactions. Clin Rev Bone Miner Metab 12(2):86–92
Gusmao-Sena MH, Curvello-Silva K, Barreto-Medeiros JM, Da-Cunha-Daltro CH (2016) Association between sarcopenic obesity and cardiovascular risk: where are we? Nutr Hosp 33(5):592
Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG (2014) Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 62(2):253–260
Inzerillo AM, Epstein S (2004) Osteoporosis and diabetes mellitus. Rev Endocr Metab Disord 5(3):261–268
Ho-Pham LT, Chau PMN, Do AT, Nguyen HC, Nguyen TV (2018) Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study. Osteoporos Int 29(9):2059–2067
Russell-Jones D, Khan R (2007) Insulin-associated weight gain in diabetes—causes, effects and co** strategies. Diabetes Obes Metab 9(6):799–812
Morley JE (2008) Diabetes, sarcopenia, and frailty. Clin Geriatr Med 24(3):455–469, vi
Plotnikoff RC, Taylor LM, Wilson PM, Courneya KS, Sigal RJ, Birkett N, Raine KI, Svenson LW (2006) Factors associated with physical activity in Canadian adults with diabetes. Med Sci Sports Exerc 38(8):1526–1534
De Vries H, van’t Riet J, Spigt M, Metsemakers J, van den Akker M, Vermunt JK, Kremers S (2008) Clusters of lifestyle behaviors: results from the Dutch SMILE study. Prev Med 46(3):203–208
Al Saedi A, Hassan EB, Duque G (2019) The diagnostic role of fat in osteosarcopenia. J Lab Precis Med. https://doi.org/10.21037/jlpm.2019.02.01
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Noushin Fahimfar, Farbod Zahedi Tajrishi, Safoora Gharibzadeh, Gita Shafiee, Kiarash Tanha, Ramin Heshmat, Iraj Nabipour, Alireza Raeisi, Ali Jalili, Bagher Larijani, and Afshin Ostovar declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
The BEH program was received the ethical approval of both Bushehr University of Medical Sciences and Endocrinology and Metabolism Research Institute. Informed consent was obtained from all participants included in the BEH program.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fahimfar, N., Zahedi Tajrishi, F., Gharibzadeh, S. et al. Prevalence of Osteosarcopenia and Its Association with Cardiovascular Risk Factors in Iranian Older People: Bushehr Elderly Health (BEH) Program. Calcif Tissue Int 106, 364–370 (2020). https://doi.org/10.1007/s00223-019-00646-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-019-00646-6